ArticleBMC ophthalmology2025
Single-pass four-throw pupilloplasty and phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Consensus on Diagnostic Criteria, Clinical Symptoms, and Risk Factors for Visual Fatigue: A Modified Delphi Study.Ophthalmology and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis prospective study aimed to assess the efficacy and safety of single-pass four-throw pupilloplasty combined with phacoemulsification and intraocular lens implantation in patients with acute angle-closure glaucoma who experienced their first acute attack and were unable to recover their pupils with medication and/or laser.
methodsSwept-source anterior segment optical coherence tomography was performed to measure anterior chamber angle parameters. Efficacy indicators included the intraocular pressure (IOP) and degree of decrease, changes in anterior chamber parameters, medication dosage, and success rate. Safety indicators included best corrected visual acuity, corneal endothelial cell examination and incidence of complications.
resultsThe mean postoperative follow-up time was 12.80 ± 4.47 months. The mean highest IOP was 51.97 ± 5.87 mmHg (range 36–61 mmHg), the mean preoperative IOP was 37.85 ± 13.14 mmHg (range 12–61 mmHg); mean postoperative IOP was lower than that before. The mean preoperative LogMAR visual acuity was 0.75 ± 0.27 and it improved 1 year postoperatively (0.2 ± 0.08; p < 0.05). The mean number of IOP-lowering drugs was lower after surgery. The number of corneal endothelial cells before and after surgery was comparable, while the mean pupil diameter was smaller after surgery. The mean central anterior chamber depth and volume were greater after surgery. The mean angle opening distance and trabecular iris angle at 500 μm were significantly larger postoperatively. At 1-year postoperatively, the absolute success rate was 86.36%, the qualified success rate was 90.91%.
conclusionsSingle-pass four-throw pupilloplasty combined with phacoemulsification and intraocular lens implantation is effective and safe for acute angle-closure glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.